AI and PET scans could replace needle biopsies for prostate cancer grading
NCT ID NCT07266129
First seen Dec 09, 2025 · Last updated Jun 18, 2026 · Updated 26 times
Summary
This study tests whether combining PSMA PET scans with machine learning can accurately grade prostate cancer without invasive biopsies. Researchers will enroll 220 men with suspected or confirmed prostate cancer. If successful, this approach could reduce unnecessary biopsies and help doctors better identify aggressive tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Universitetssykehuset Nord Norge, Tromsø
RECRUITINGTromsø, Troms, 9019, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.